Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy

E Ruggeri, F Frezzato, N Mouawad, M Pizzi… - Frontiers in …, 2024 - frontiersin.org
… , multiple myeloma and non-Hodgkin lymphomas (15–18). … Cell viability was measured
through Trypan blue exclusion … In this work, we characterized the role of protein kinase CK2

Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research

S Manni, A Fregnani, G Barilà, R Zambello… - Frontiers in …, 2020 - frontiersin.org
cells rely on high expression of replication related proteins … has described the role of protein
kinase CK1α and CK1δ in the … stress management for myeloma cell survival. Cottini et al. (…

Regulation of cancer progression by CK2: an emerging therapeutic target

S Hussain, Y Guo, Y Huo, J Shi, Y Hou - Medical Oncology, 2024 - Springer
… a particularly strong reliance on increased eIF4F activity for … The role of protein kinase CK2
in the process of proper B cell … Fifth, CK2 is essential for cell viability, and currently, there …

Mitigation of aberrant CK2 expression in various cancer types

M Mallouh - 2021 - search.proquest.com
… in inhibiting CK2, displaying reduction of cell viability, decreased cellProtein kinases are a
set of enzymes that catalyze the … associated tyrosine kinases) by OSM is dependent on CK2, …

Protein kinase CK2 regulates B cell development and differentiation

H Wei, W Yang, H Hong, Z Yan, H Qin… - The Journal of …, 2021 - journals.aai.org
… sustains prosurvival and proliferative signaling cascades that depend on NF-κB, PI3K/AKT/…
cycling under homeostatic conditions, we next analyzed cell survival. Splenic FoB and MZB …

Strategies of targeting CK2 in drug discovery: challenges, opportunities, and emerging prospects

Y Chen, Y Wang, J Wang, Z Zhou, S Cao… - Journal of Medicinal …, 2023 - ACS Publications
… that depend on high levels of CK2 (EC 50 = 6.19 μM) by … Compound 64 influenced cell
viability by inducing apoptosis, … , LA Unique activation mechanism of protein kinase CK2. The N-…

Pathways of angiogenic and inflammatory cytokines in multiple myeloma: role in plasma cell clonal expansion and drug resistance

A Melaccio, A Reale, I Saltarella, V Desantis… - Journal of Clinical …, 2022 - mdpi.com
… stromal cells (BMSCs), a hallmark of MM progression, is based … -22 activates JAK1,
tyrosine-protein kinase (Tyk)2 and MAPK … of cell survival, angiogenesis and tumor progression …

Inhibition of Casein Kinase 2 induces cell death in chronic myelogenous leukemia cells resistant to tyrosine kinase inhibitors

O Mitrovský, D Myslivcová, T Macháčková-Lopotová… - bioRxiv, 2021 - biorxiv.org
… that CK2 kinase supports CML cell viability even in cells with … that in resistant cells, CK2
activity is dependent on that of … Pharmacological inhibition of protein kinase CK2 reverts the …

Development of a potent and selective chemical probe for the pleiotropic kinase CK2

CI Wells, DH Drewry, JE Pickett, A Tjaden, A Krämer… - Cell chemical …, 2021 - cell.com
… -CK2-1) as a highly potent and cell-active CK2 chemical probe with exclusive selectivity for
both human CK2 … of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer. …

Resistance to the proteasome inhibitors: Lessons from multiple myeloma and mantle cell lymphoma

M Gonzalez-Santamarta, G Quinet… - … and Disease: From …, 2020 - Springer
… in cell cycle, DNA damage response, or cell survival pathways, … antiapoptotic proteins
of the BCL-2 family, MM cells depend … 6 (ATF6), protein kinase R (PKR)-like ER kinase (PERK)-…